Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial

Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial

Abstract Background HIV-infected individuals on antiretroviral therapy (ART) require treatment with artemisinin-based combination therapy (ACT) when infected with malaria. Artemether–lumefantrine (AL) is the most commonly used ACT for treatment of falciparum malaria in Africa but there is limited ev...

Full description

Bibliographic Details
Main Authors: Clifford G. Banda, Mike Chaponda, Mavuto Mukaka, Modest Mulenga, Sebastian Hachizovu, Jean B. Kabuya, Joyce Mulenga, Jay Sikalima, Linda Kalilani-Phiri, Dianne J. Terlouw, Saye H. Khoo, David G. Lalloo, Victor Mwapasa
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Malaria Journal
Subjects:
Human immunodeficiency virus
Anti-retroviral drugs
Artemether–lumefantrine
Malaria
Drug–drug interactions
Online Access:http://link.springer.com/article/10.1186/s12936-019-2818-7

Internet

http://link.springer.com/article/10.1186/s12936-019-2818-7

Similar Items